Home
About Us
Products
Manus Aktteva Biopharma LLP, an ISO 9001: 2008 certified sourcing & export concern takes pride in fulfilling your requirements of Nutraceuticals, Specialty Chemicals, Pharmaceutical APIs and their advance level intermediates from ISO Certified, GMP, CGMP & USFDA approved units with supportive regulatory documentations like DMF, EDMF, COS, USDMF etc. We wish to state that anyone interested in sourcing any special molecules, APIs, Intermediates, Chiral Compounds etc. and feels it is difficult for early completion of tasks, please call on us and TEST US TO GET THE BEST OF US.
Category
Recommended
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk. Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1)
Enquiry
Quick Links
Blog
Contact Us

Itopride hydrochloride (CAS No.: 122892-31-3)

Manus Aktteva Biopharma LLP, a global supplier of Itopride hydrochloride, 122892-31-3 offers for your requirements of RND / Development quantities or commercials, based on status of the product. We can also offer its intermediates with supportive technical package required for evaluation.

CAS number:

122892-31-3

Chemical Name:

Itopride hydrochloride, Itopride hydrochloride (CAS No.: 122892-31-3)

Pharmacopeia:

IP, In House

Certificate:

GMP, GMP - SFDA, cGMP, WHO GMP, ISO Certified, USFDA

Application:

For R&D Purpose

Properties
Related Intermediates

Synonym

N-[[4-(2-dimethylaminoethoxy)phenyl]methyl]-3,4-dimethoxy-benzamide hydrochloride , Itopride hydrochloride (CAS No.: 122892-31-3)

Molecular Formula

C20H26N2O4.HCl

Molecular Weight

394.90

Specifications

Available on request

Packing

Export worthy packing

Material Safety Data Sheet

Available on request

Product Name	CAS No.
4-(2-Dimethylamino)ethoxybenzylamine	20059-73-8	View \| Inquire
3,4-Dimethoxybenzoic acid	93-07-2	View \| Inquire
4-Hydroxybenzylamine	696-60-6	View \| Inquire
N-(4-hydroxybenzyl)-3,4-dimethoxy benzamide	943518-63-6	View \| Inquire
Itopride Base	122898-67-3	View \| Inquire

Documentation / Approvals :

USDMF	EDMF	TDP	DMF - CTD	Written Confirmation

Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1)
Products falling in to controlled substance category / list of schedule drugs shall be exported directly from the manufacturer principals only against receipt of original import permission issued by concerned authorities of the importing country.
Manus Aktteva Biopharma LLP assumes no responsibility/liability in case of being imparted with goods which infringe intellectual property in any manner whatsoever which includes patent rights of any individual. Manus Aktteva makes no representations or warranties of any kind, express or implied, about the originality or reliability with respect to the intellectual property which includes patents in its products or services for any purpose.
Manus Aktteva Biopharma LLP warns the sellers not to sell any goods which infringe intellectual property in any manner whatsoever which includes patent rights of any individual.
Manus Aktteva Biopharma LLP warns the buyers not to use/procure any goods to achieve a product which might be knowingly causing an infringement of intellectual property in any manner whatsoever which includes patent rights of any individual.

Are you looking for Itopride hydrochloride (CAS No.: 122892-31-3) with documentation like CEP / COS, PMDA - JAPAN, DMF - CANADA, TGA - AUSTRALIA, DMF (OPEN PART), DMF (CLOSED PART), MHRA - UK, DMF - KOREA, AIFA - ITALY, MEDSAFE - NEW ZEALAND, HEALTH CANADA, JDMF, JAPAN - AFM, DCGI, ICH, COPP, TDMF? Please click here to send us sourcing request.

Why Us